XML 119 R101.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Parent Company Only Condensed Financial Information, Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities [Abstract]    
Net income $ 4,514 $ 5,636
Adjustments to reconcile net loss to net cash used in operating activities [Abstract]    
Change in other assets (677) (995)
Change in accrued expenses and other liabilities 2,287 (461)
Net cash provided by operating activities 7,594 6,324
Cash flows from investing activities [Abstract]    
Net cash used in investing activities (100,044) (323,959)
Cash flows from financing activities [Abstract]    
FDIC stock repurchase (1,781) 0
Proceeds from issuance of preferred stock 0 150,000
Increase in unreleased ESOP shares (3,400) (500)
Net cash provided by financing activities 181,540 102,220
Net change in cash and cash equivalents 89,090 (215,415)
Cash and cash equivalents at beginning of the period 16,105 231,520
Cash and cash equivalents at end of the period 105,195 16,105
Broadway Financial Corporation [Member]    
Cash flows from operating activities [Abstract]    
Net income 4,514 5,636
Adjustments to reconcile net loss to net cash used in operating activities [Abstract]    
Equity in undistributed subsidiary income (5,149) (6,340)
Change in other assets (1,222) 1,196
Change in accrued expenses and other liabilities 152 (348)
Net cash provided by operating activities (1,705) 144
Cash flows from investing activities [Abstract]    
Capital distribution to bank subsidiary 0 (75,000)
Net cash used in investing activities 0 (75,000)
Cash flows from financing activities [Abstract]    
FDIC stock repurchase (1,781) 0
Proceeds from issuance of preferred stock 0 150,000
Increase in unreleased ESOP shares (3,400) (500)
Proceeds from repayment of ESOP loan 328 66
Net cash provided by financing activities (4,853) 149,566
Net change in cash and cash equivalents (6,558) 74,710
Cash and cash equivalents at beginning of the period 84,015 9,305
Cash and cash equivalents at end of the period $ 77,457 84,015
Non-cash financing activities for exchange of preferred stock for common stock   $ 3,000